Valeant names Joseph Pap CEO, chairman

http://www.marketwatch.com/story/valeant-names-joseph-c-papa-to-be-chairman-and-chief-executive-officer-of-valeant-pharmaceuticals-2016-04-25

Valeant Pharmaceuticals International, Inc. today announced that its Board of Directors has named Joseph C. Papa to become Valeant's Chairman and Chief Executive Officer.  Mr. Papa is expected to join Valeant by early May.  Mr. Papa will join Valeant from Perrigo Company plc, a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, where he served as Chairman and Chief Executive Officer.  Mr. Papa, who will also join Valeant's Board of Directors, will succeed J. Michael Pearson, who is expected to remain as CEO and a director until Mr. Papa arrives at Valeant. Mr. Papa, 60, has more than 35 years of experience in the pharmaceutical, healthcare services and specialty pharmaceutical industries,